abstract |
The present invention relates to the development and manufacture of viral vaccines. Specifically, the present invention relates to the field of industrial production of viral vectors and vaccines, and more particularly to the use of EBx® cell lines derived from avian embryonic stem cells, preferably duck embryonic stem cells, for the production of viral vectors and viruses. It is about. In particular, the present invention is useful for the industrial production of viral vaccines for preventing viral infections of humans and animals. |